Social Media for Exploring Adverse Drug Events Associated with Multiple Sclerosis

Abstract

Multiple Sclerosis (MS) affects 400,000 people in the USA and almost 2.5 million people worldwide. There is no cure for MS. A variety of disease-modifying therapies are currently available. They aim to reduce disease activity that ultimately leads to disability. However, such drugs have adverse effects that vary widely among patients making the choice of a suitable drug particularly challenging. With the proliferation of social media, this research aims to understand the perspective of people with MS on social media (Twitter) in regard to Adverse Drug Events (ADEs) and to analyze ADEs as perceived by MS patients. This study helps in understanding ADEs associated with MS drugs and can further inform future medical research by highlighting and prioritizing additional clinical trials needed to better assess such adverse drug effects.